{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:41:44Z","timestamp":1791081704969,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Idiopathic pulmonary fibrosis (IPF) is serious chronic lung disease with limited therapeutic approaches. Inflammation and immune disorders are considered as the main factors in the initiation and development of pulmonary fibrosis. Inspired by the key roles of macrophages during the processes of inflammation and immune disorders, here, we report a new method for direct drug delivery into the\n                    <jats:italic>in-situ<\/jats:italic>\n                    fibrotic tissue sites\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . First, liposomes containing dexamethasone (Dex-L) are prepared and designed to entry into the macrophages in the early hours, forming the macrophages loaded Dex-L delivery system (Dex-L-MV). Chemokine and cytokine factors such as IL-6, IL-10, Arg-1 are measured to show the effect of Dex-L to the various subtypes of macrophages. Next, we mimic the inflammatory and anti-inflammatory microenvironment by co-culture of polarized\/inactive macrophage and fibroblast cells to show the acute inflammation response of Dex-L-MV. Further, we confirm the targeted delivery of Dex-L-MV into the inflammatory sites\n                    <jats:italic>in vivo<\/jats:italic>\n                    , and surprisingly found that injected macrophage containing Dex can reduce the level of macrophage infiltration and expression of the markers of collagen deposition during the fibrotic stage, while causing little systematic toxicity. These data demonstrated the suitability and immune regulation effect of Dex-L-MV for the anti-pulmonary process. It is envisaged that these findings are a step forward toward endogenous immune targeting systems as a tool for clinical drug delivery.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.613907","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:12:50Z","timestamp":1613812370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Macrophage-Targeted Lung Delivery of Dexamethasone Improves Pulmonary Fibrosis Therapy via Regulating the Immune Microenvironment"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoqing","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"George","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-med-041317-102715","article-title":"Progress in understanding and treating idiopathic pulmonary fibrosis","volume":"70","author":"Kropski","year":"2019","journal-title":"Annu Rev Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","article-title":"Inflammation and immunity in IPF pathogenesis and treatment","volume":"147","author":"Heukels","year":"2019","journal-title":"Respir Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: friend or foe in idiopathic pulmonary fibrosis?","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.immuni.2019.06.014","article-title":"Targeting degradation of the transcription factor C\/EBPbeta reduces lung fibrosis by restoring activity of the ubiquitin-editing enzyme A20 in macrophages","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/17435390.2018.1425501","article-title":"Macrophage polarization and activation at the interface of multi-walled carbon nanotube-induced pulmonary inflammation and fibrosis","volume":"12","author":"Dong","year":"2018","journal-title":"Nanotoxicology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20162152","article-title":"Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span","volume":"214","author":"Misharin","year":"2017","journal-title":"J Exp Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-417028-5.00006-5","article-title":"Macrophage activation and polarization as an adaptive component of innate immunity","volume":"120","author":"Locati","year":"2013","journal-title":"Adv Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/icb.2017.64","article-title":"Macrophage polarization and function: new prospects for fibrotic disease","volume":"95","author":"Zhou","year":"2017","journal-title":"Immunol Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12964-018-0300-8","article-title":"M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis","volume":"16","author":"Hou","year":"2018","journal-title":"Cell Commun Signal."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.7150\/thno.33520","article-title":"Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and fibrosis","volume":"9","author":"Tang","year":"2019","journal-title":"Theranostics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1039\/c8bm00218e","article-title":"Targeted delivery of tungsten oxide nanoparticles for multifunctional anti-tumor therapy via macrophages","volume":"6","author":"Zheng","year":"2018","journal-title":"Biomater Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1805557","DOI":"10.1002\/adma.201805557","article-title":"Nanoparticle-laden macrophages for tumor-tropic drug delivery","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv Mater."},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","article-title":"Polarizing macrophages in vitro","volume":"1784","author":"Huang","year":"2018","journal-title":"Methods Mol Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bcp.2018.05.007","article-title":"Quercetin ameliorates kidney injury and fibrosis by modulating M1\/M2 macrophage polarization","volume":"154","author":"Lu","year":"2018","journal-title":"Biochem Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1007\/s10753-017-0646-x","article-title":"Aucubin alleviates bleomycin-induced pulmonary fibrosis in a mouse model","volume":"40","author":"Zhou","year":"2017","journal-title":"Inflammation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.7150\/thno.20270","article-title":"Dioscin exerts protective effects against crystalline silica-induced pulmonary fibrosis in mice","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics."},{"key":"B22","doi-asserted-by":"publisher","first-page":"110364","DOI":"10.1016\/j.ecoenv.2020.110364","article-title":"Silica particles disorganize the polarization of pulmonary macrophages in mice","volume":"193","author":"Zhao","year":"2020","journal-title":"Ecotoxicol Environ Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"Saito","year":"2008","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40248-017-0089-0","article-title":"Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice","volume":"12","author":"Ruscitti","year":"2017","journal-title":"Multidiscip Respir Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"56443","DOI":"10.3791\/56443","article-title":"A multimodal imaging approach based on micro-CT and fluorescence molecular tomography for longitudinal assessment of bleomycin-induced lung fibrosis in mice","volume":"134","author":"Ruscitti","year":"2018","journal-title":"J Vis Exp."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1039\/d0nr00750a","article-title":"Nanoengineered immunosuppressive therapeutics modulating M1\/M2 macrophages into the balanced status for enhanced idiopathic pulmonary fibrosis therapy","volume":"12","author":"Chang","year":"2020","journal-title":"Nanoscale."},{"key":"B27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejphar.2010.05.019","article-title":"A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis","volume":"642","author":"Baowen","year":"2010","journal-title":"Eur J Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10737","DOI":"10.1038\/s41598-017-11450-3","article-title":"Cholesterol-modified hydroxychloroquine-loaded nanocarriers in bleomycin-induced pulmonary fibrosis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1513\/pats.200907-061RM","article-title":"Nanoparticles as a potential cause of pleural and interstitial lung disease","volume":"7","author":"Bonner","year":"2010","journal-title":"Proc Am Thorac Soc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12544","DOI":"10.1039\/c5nr07796f","article-title":"Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions","volume":"8","author":"Leonard","year":"2016","journal-title":"Nanoscale."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1021\/acs.nanolett.8b01236","article-title":"Bioengineered macrophages can responsively transform into nanovesicles to target lung metastasis","volume":"18","author":"Cao","year":"2018","journal-title":"Nano Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10717544.2016.1230903","article-title":"A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles","volume":"24","author":"Pang","year":"2017","journal-title":"Drug Deliv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol Aspects Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jconrel.2017.01.048","article-title":"Cell-mediated delivery of synthetic nano- and microparticles","volume":"259","author":"Ayer","year":"2017","journal-title":"J Control Release."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9610","DOI":"10.1021\/acsami.6b00853","article-title":"Macrophage cell membrane camouflaged au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy","volume":"8","author":"Xuan","year":"2016","journal-title":"ACS Appl Mater Interfaces."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:12:56Z","timestamp":1613812376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.613907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2021.613907"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.613907","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"article-number":"613907"}}